NCT01519856View on ClinicalTrials.gov

PIRLONG-PD Safety and Efficacy of Piribedil in Parkinson's Disease During Long Term Therapy

CompletedOBSERVATIONAL
Enrollment

908

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

December 31, 2014

Study Completion Date

February 28, 2015

Conditions
Parkinson's Disease
Interventions
DRUG

piribedil (Clarium)

oral tablets, 50 mg

Trial Locations (1)

71034

Dr. Erich Scholz, Böblingen

Sponsors
All Listed Sponsors
lead

Desitin Arzneimittel GmbH

INDUSTRY

NCT01519856 - PIRLONG-PD Safety and Efficacy of Piribedil in Parkinson's Disease During Long Term Therapy | Biotech Hunter | Biotech Hunter